PARP16 and cardiac hypertrophy: PARP16 deficiency alleviates cardiac dysfunction, attenuates transverse aortic constriction‐induced cardiac hypertrophy/fibrosis, and reduces phenylephrine‐induced cardiomyocyte hypertrophic responses.